Angela Caglia Skincare introduces patented human stem cell tech



Angela Caglia, Master Esthetician and skin care formulator, has debuted her self-named skin care brand’s Cellular Collection, which leverages human mesenchymal stem cells (MSCs) byproducts in skin care. The first product in this line, Cell Forté Serum, utilizes the world’s first patented human-derived stem cell technology byproduct, according to Caglia, marking a significant innovation in non-invasive anti-aging solutions.

Caglia’s formulation approach could have far-reaching implications for the cosmetics and personal care industry as the demand for advanced, science-backed skin care products continues to grow, and we spoke to her to learn more about the science behind the product launch.

Stem cell technology in skin care

The core innovation of Cell Forté Serum lies in its use of byproducts from MSCs, which were originally studied for their healing properties in treating conditions such as dementia, Parkinson’s disease, and arthritis. Now, these same regenerative capabilities are being applied to skin care.

“MSC’s contain healing properties that help prevent UV-induced skin damage and promote cell regeneration,” Caglia explained. However, she clarified that the actual stem cells are not present in the formulation. “There are no MSCs in our skin care,” she said, as “the stem cells wouldn’t survive in the jar nor penetrate the skin due to their molecular size.”

Instead, she shared, “we use the byproduct of MSCs, duplicated and created under sterile cGMP-certified lab conditions.” This distinction emphasizes the role of exosomes, growth factors, and cytokines derived from MSCs as the active components driving skin regeneration in the serum.



Source link

About The Author

Scroll to Top